Membrane lipid peroxidation at the level of the retina is an early pathological aspect of oxidative stress in diabetes [1, 2] . Direct evidence of oxidative stress, however, has not yet been found in diabetic retinal photoreceptors, even though their high physiological production rate of reactive molecular species [3] and their abundant unsaturated fatty acids make these cells a principal substrate for lipid peroxidation.
injected hamsters compared with the control hamsters matched for age. Similar effects were obtained in control photoreceptors after 40 min incubation with 2±2'-azobis (2-amidinopropane) dihydrochloride, a potent lipoperoxidation inducer. The effect of melatonin was to partially restore the light-induced fluorescence response. Conclusion/interpretation. The depression of the light-induced oxidative response in diabetic photoreceptors could be ascribed to a hyperglycaemiainduced background of oxidative stress whereby the light-oxidizable substrate is actually lowered. Melatonin induces a larger fluorescence response during illumination, probably as a consequence of its antioxidant effect during diabetes, which would provide more oxidizable lipids. [Diabetologia (2002) of intracellularly preloaded dehydrorhodamine (DHR) 123 into fluorescent rhodamine (RHO) 123, and by the presence of high levels of thiobarbituric acid reactive substances [4, 5] .
In this study we used this experimental model to verify directly whether hamster retinal rod photoreceptor cells undergo a light-induced oxidative stress as happens in frogs [4] , and whether streptozotocin (STZ)-induced diabetes alters this oxidative process. This investigation is based on the assumption that if, during the course of diabetes, retinal rod photoreceptor cells undergo an increased lipoxygenation, this lipoxygenation might decrease the lipid substrate available for further oxidation by light, thereby reducing light-induced damage to photoreceptor cells and their fluorescence response. According to this hypothesis if melatonin, an antioxidant synthesized in retinal rod photoreceptor cells [4] , is given during diabetes, then more oxidizable lipids should be available to enhance the light-induced fluorescence response.
Materials and methods
A total of 33 male Syrian hamsters, 70±90 g body wt., (Charles River, Calco, Italy) were used: 11 were injected with the vehicle, serving as age-matched controls; 22 were injected with STZ (Sigma Chemical, St. Louis, Mass., USA), 50 mg/kg body wt., i. p., (DIA group). Eleven were treated with melatonin every day after 15 days (Sigma), 0.4 mg/kg body wt., per os, (DIA + MLT group). Blood glucose, cholesterol and triglycerides were measured by colorimetric methods (Roche Diagnostics, Monza, Italy) on blood samples withdrawn from the heart under light thiopental anesthesia (Pentothal Sodium, Gellini, Aprilia, Italy), 30 mg/kg body wt., i. p., before and 90 days after STZ administration. Hamsters were kept and killed in accordance with principles of laboratory animal care and the institutional rules for care and handling of experimental animals.
Single photoreceptor outer segments (POS) were isolated from dark-adapted retinas 90 days after STZ injection and placed on a Petri dish filled with Locke's solution containing (in mmol/l): NaCl, 140; KCl, 3.6; CaCl 2 , 1.2, MgCl 2 , 2.4; HE-PES, 10, Glucose, 10, at pH 7.6 [3] . Microscopic analysis did not reveal any morphological difference between retinal rod photoreceptor cells isolated from control and STZ-injected hamsters. DHR 123 (Molecular Probes, Eugene, Ore., USA), which in the presence of reactive oxygen species is oxidized into fluorescent RHO 123 [6] , was added to the cell-containing suspension at a final concentration of 10 mmol/l, and allowed to diffuse for 20 min at 37 C. A drop of the cell suspension was then placed on a microscope slide for observation under fluorescence illumination. Fluorescent microscopy was carried out by epiilluminating POS with the mercury arc lamp (OS-RAM) of a Leitz Orthoplan microscope, filtered at 485 nm ( + /-8 nm) for excitation, and at 520 ( + /-8 nm) for emission. The same light used for RHO 123 excitation was also used for POS light stimulation (a circle of 20 mm diameter, 4.2´10 4 ph s ±1 cm ±2 ). A photometric detector (818 ST, Newport, Irvine, Calif., USA), applied to the microscope, measured the irradiance from the POS and fed results into an A/D converter (Labmaster, Axon Instruments, Foster City, Calif., USA) for further computer-assisted data analysis (Origin, MicroCal Software, Northampton, Mass., USA).
Twenty minutes before incubation with DHR 123, 2±2'-azobis (2-amidinopropane) dihydrochloride (ABAP) (Wako Chemicals, Dallas, Tex., USA), a water-soluble initiator of lip- Table 1 . Weight, blood glucose, cholesterol, triglycerides, amplitude of fluorescence peak and time to peak of photoreceptor light-induced fluorescence response in age-matched control (CON), age-matched control treated with 2±2'-azobis *p < 0.01, significantly different compared to control animals (CON) **p < 0.01, significantly different compared to diabetic animals (DIA) id peroxidation [7] , was added to CON POS-containing suspensions (CON + ABAP group, n = 22 cells) at a final concentration of 2.5 mmol/l.
Data were analysed for statistical significance using the Mann-Whitney and Kruskal-Wallis non-parametric tests. The reported values are means SEM; differences were considered to be statistically significant at p < 0.05.
Results
Animal weight, blood glucose, cholesterol and triglycerides all showed a successfully developed experimental diabetes at 90 days after STZ injection (Table 1). The 75-day-long treatment with melatonin did not seem to significantly reduce any of these clinical characteristics.
The control group showed a typical light-induced fluorescence increase recorded photometrically from the POS, reflecting the production of oxidant species during illumination (Fig. 1) . The light-induced oxidation slowly rises during an initial phase of 50±70 s, followed by a steeper increase, peaking at about 120 s.
In the diabetic group, diabetes greatly reduced and delayed the light-induced fluorescence response (Fig. 1) . To test the hypothesis that the reduction observed in the fluorescence response resulted from oxidative stress during diabetes, lipid peroxidation was artificially initiated by adding ABAP (2.5 mmol/l final concentration), 40 min before the illumination of POS isolated from the group of control animals. In the control group with ABAP, the antecedent ABAP-induced lipid peroxidation reduced the peak amplitude of the fluorescence response to illumination (Fig. 1) .
Melatonin, administered to diabetic hamsters from 15 days after STZ injection, partially restored the fluorescence response to light (Fig. 1) .
The fluorescence peak amplitude and the time to peak of the diabetic group, the control group with ABAP and the diabetic group with MLT were significantly different from the control group (Table 1) . Furthermore, a significant difference was observed between the diabetic group and the diabetic group with MLT.
Discussion
Our data indicate oxidative stress in Syrian hamster retinal rod photoreceptor cells during diabetes whereby the light-induced oxidative response almost completely disappears. This result could be due to a change in the phospholipid fatty acid composition because of long-standing lipoxidation in photoreceptors, which is known to occur in other tissues during diabetes [8] . This process could be particularly damaging for retinal rod photoreceptor cells because of their specific membrane phospholipid composition, their high and steady production rate of oxyradicals deriving from a sustained energy demand [3] and the deterioration of the G-protein complex [9] during oxidative stress, thus favouring cytotoxicity.
The experiment with ABAP, where lipid peroxidation was initiated before light stimulation, confirms that a pre-existing oxidative stress could reduce the subsequent light-induced oxidative response.
The suggestion that oxidative stress develops in retinal rod photoreceptor cells during diabetes is further supported by the effects of melatonin, recently shown to be a potent antioxidant synthesized in these cells [4, 10] . Melatonin, by inhibiting, at least partially, oxidative stress during diabetes, an effect possibly associated with up-regulation of anti-oxidative and/ or anti-apoptotic genes [11] , might preserve more polyunsaturated fatty acids which are subsequently oxidized by light. Further studies are needed to show these mechanisms. This protective effect of melatonin argues against the possibility that a reduced amount or function of rhodopsin accounts for the disappearance of the photooxidative response.
However, a variation in the phospholipid fatty acid composition, in addition to altering their susceptibility to oxidation, might also reduce the retinal capacity for photon absorption [12] . Ongoing analytical studies will verify the expected changes in the relative lipid composition of photoreceptors during STZ-induced diabetes.
The alterations in membrane lipid metabolism might be responsible for functional disorders in diabetic retinal rod photoreceptor cells; in this case the 
